Dermatologic Adverse Events Associated With Afatinib: An Oral ErbB Family Blocker
March 2013
in “
Expert Review of Anticancer Therapy
”
Studysummary This article summarizes dermatologic adverse events in patients treated with afatinib in clinical trials and discusses strategies for managing these side effects, without providing new clinical results.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer